FDA Recalls Some Valsartan Drugs Due to Impurity
Title: FDA Recalls Some Valsartan Drugs Due to ImpurityCategory: Health NewsCreated: 7/16/2018 12:00:00 AMLast Editorial Review: 7/16/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 16, 2018 Category: Cardiology Source Type: news
FDA Recalls Some Valsartan Drugs Due to Impurity
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 16, 2018 Category: General Medicine Source Type: news
FDA Recalls Common Heart Drug For Potential Cancer Risk
(CNN) — The recall of a common drug used to control blood pressure and help prevent heart failure was announced by the US Food and Drug Administration on Friday, a week after 22 other countries recalled it because the drug contains a chemical that poses a potential cancer risk.
Valsartan is off patent and is used as a component of other generic medicines, but not all medicines containing the ingredient are involved, according to the FDA. The US recall includes the the versions of valsartan that are made by Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals Industries Ltd. as well as valsartan/hydrochlor...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 16, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Valsartan Source Type: news
FDA Recalls Some Valsartan Medicines Due to Impurity FDA Recalls Some Valsartan Medicines Due to Impurity
Three companies are recalling several drug products containing valsartan due to the presence of N-nitrosodimethylamine, which is classified as a probable human carcinogen.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 14, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news
Prinston Pharmaceutical Inc Issues Voluntary Nationwide Recall of Valsartan and Valsartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in The Products
Prinston Pharmaceutical Inc. dba Solco Healthcare LLC. is recalling all lots of Valsartan Tablets, 40 mg, 80mg, 160mg, and 320mg; and Valsartan-Hydrochlorothiazide Tablets, 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg, and 320mg/25mg to the retail level. This product recall is due to the detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA), made by the manufacturer – Zhejiang Huahai Pharmaceutical Co. Ltd. -- that is used in the manufacture of the subject product lots. This impurity has been classified as a probable human carcinogen as per International Agency for Research on Cance...
Source: Food and Drug Administration - July 13, 2018 Category: Food Science Source Type: news
FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity
FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure (Source: Food and Drug Administration)
Source: Food and Drug Administration - July 13, 2018 Category: American Health Source Type: news
FDA Announces Voluntary Recall of Several Medicines Containing Valsartan Following Detection of an Impurity
July 13, 2018 -- The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2018 Category: Pharmaceuticals Source Type: news
Class 1 Medicines Recall: Action Now including out of hours Pharmacy Level Recall: Superseded drug alert - Valsartan/Hydrochlorothiazide 160/12.5mg Film-Coated Tablets
The Medicines& Healthcare products Regulatory Agency (MHRA) issued a Class 1 Medicines Recall (Drug Alert EL (18)A/11) on 5th July 2018. Pharmacies in the UK were asked to recall all batches of v (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 11, 2018 Category: Drugs & Pharmacology Source Type: news
Some heart, high blood pressure drugs containing valsartan recalled due to cancer risk
Several heart and high blood pressure drugs that contain valsartan are being recalled because of a substance that can cause cancer. (Source: CBC | Health)
Source: CBC | Health - July 10, 2018 Category: Consumer Health News Tags: News/Health Source Type: news
Morning Break: Burnout Errors; Trump Bashes Pfizer; Valsartan Recall
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 10, 2018 Category: American Health Source Type: news
Common Heart Drug Recalled In 22 Countries For Possible Cancer Link
(CNN) — A common drug used to control blood pressure and help prevent heart failure is being recalled in 22 countries because it contains a chemical that poses a potential cancer risk.
Valsartan is off-patent and is used as a component of other generic medicines. Novartis, the company that originally developed the drug, said Sandoz valsartan and valsartan/HCT film-coated tablets are being recalled since they “do not meet our high quality standards.” Pharmacies in the UK are advised to recall valsartan batches containing medicines made by Dexcel Pharma Ltd and Accord Healthcare.
The recall involves about 2...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 6, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Valsartan Source Type: news
Common heart drug is recalled in 22 countries for possible cancer link
The heart medicine valsartan is being recalled in 22 countries due to a potential cancer risk. (Source: CNN.com - Health)
Source: CNN.com - Health - July 6, 2018 Category: Consumer Health News Source Type: news
